U.S. pharma giant copyright scrapped two experimental weight loss capsules final year—a at the time-daily capsule, lotiglipron, as a result of elevated liver enzymes plus a two times-daily pill, danuglipron, as a result of solid side effects—but CEO Albert Bourla has explained the company is decided to “Perform and earn” during the weight p